Condition
Long-acting Injectable Cabotegravir for PrEP
Total Trials
4
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting3
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07516548Not Yet Recruiting
Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV
NCT07579754Not ApplicableRecruitingPrimary
BetterInfo on Women's PrEP Choices and Outcomes in Malawi
NCT07221747Not ApplicableRecruiting
PathToScale: The PERSIST Trial
NCT06319105Recruiting
PathToScale: An Implementation Evaluation
Showing all 4 trials